Drugs / PEG-Formulation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01765114 | Feb 2013 → Aug 2014 | genital herpes | Devirex AG | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG-Formulation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01765114 ↗ |